BioWorld

May 21, 2012

View Archived Issues

BioWorld Stock Report For Public Biotechnology Companies

Stock Gainers and Losers For The Week

Money Raised by Biotech Jan. 1 - May 18, 2012

Money Raised by Biotech 2012 Vs. 2011

Biotech-Biotech Collaborations: Modified And Terminated Agreements: April 1 - May 18, 2012

Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: April 1 - May 18, 2012

Biotechnology Company Deals With Other Biotechnology Companies: April 1 - May 18, 2012

Top Deals Between Biotech Companies: 2012

Investment Practice Changes By LPs Could Help Startups

The Ewing Marion Kauffman Foundation issued a report this month blaming the lackluster returns from venture capital on a lack of oversight from limited partners (LPs) that invest in the funds. Read More

Novartis Expands R&D as Other Pharmas Cut Back

At a time when many big pharmas are trimming internal research programs, Novartis AG has been quietly expanding. Read More

Week in Review

Word on the Street

Week in Washington

Today's news in brief

BioWorld

BioWorld briefs for June 11, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...